Does adding coenzyme Q10 to dehydroepiandrosterone sulphate positively impact fertility outcomes in young, poor responder infertile women undergoing antagonist protocol for IVF/ICSI cycles?
Main Article Content
Abstract
Background. One of the biggest issues in reproductive medicine is treating women with low ovarian reserves or a poor ovarian response (POR) to stimulation. Oxidative stress was suggested as one of the major contributors to POR. However, the pathophysiology remains unknown. Focusing on certain subpopulations within the diverse group of poor responders may help determine the best therapy for these patients.
Objective. To investigate the effect of adding coenzyme A Q10 to dehydroepiandrosterone (DHEA) in young, poor responder infertile females undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles.
Methods. One hundred and sixty-eight females with poor ovarian response (Poseidon Group 3) from multiple centres were randomly divided into two groups. The first group received DHEA orally along with coenzyme 10, while the second group received only DHEA. Both groups underwent controlled ovarian stimulation.
Results. There was a significant improvement in the quality of oocytes and the number and quality of embryos transferred in the coenzyme A Q10 group. However, no significant differences were observed in other parameters between the groups.
Conclusion. In young, poor-responder women with decreased ovarian reserve, pretreatment with CoQ10 enhances oocyte and embryo quality and boosts ovarian response to stimulation. An improvement in clinical pregnancy and live birth rates may be possible.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJOG is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer S. The poor responder in IVF: Is the prognosis always poor? A systematic review. Hum Reprod Update 2012;18(1):1- 11. https://doi.org/10.1093/humupd/dmr037
Pandian Z, McTavish A, Aucott L, Hamilton M, Bhattacharya S. Interventions for poor responders to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane 2010;20(1). https://doi.org/10.1002/14651858. CD004379.pub3
Szymusik I, Marianowski P, Zygula A, Wielgos M. Poor responders in IVF–is there any evidence-based treatment for them? Neuroendocrinol Lett 2015;36(3).
Patrizio P, Vaiarelli A, Setti PE, Tobler KJ, Shoham G, Leong M, Shoham Z. How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reprod Biomed 2015;30(6):581-592. https://doi. org/10.1016/j.rbmo.2015.03.002
Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: Reliability and utility. Curr Opin Obstet Gynecol 2010;22(4):271-276.
Hyman JH, Margalioth EJ, Rabinowitz R, Tsafrir A, Gal M, Alerhand S, Algur N, Eldar-Geva T. DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism. Eur J Obstet Gynecol Reprod Biol 2013;168(1):49- 53. https://doi.org/10.1016/j.ejogrb.2012.12.017
Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005;84(3):756-e1. https://doi.org/10.1016/j. fertnstert.2005.02.049
Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21(11),2845-2849.
Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad D. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case-control study. Reprod Biol Endocrinol 2009;7(1):1-7. https://doi.org/10.1186/1477-7827-7-108
Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor- responder patients before and during IVF treatment improves the pregnancy rate: A randomised prospective study. Hum Reprod 2010;25(10),2496-2500. https://doi.org/10.1093/ humrep/deq220
Kolibianakis EM, Venetis CA, Tarlatzis BC. DHEA administration in poor responders. Human Reprod 2011;26(3),730-731. https://doi.org/10.1093/humrep/deq397
Urman B, Yakin K. Does dehydroepiandrosterone have any benefit in fertility treatment? Curr Opin Obstet Gynaecol 2012;24(3),132-135.
Kara M, Aydin T, Aran T, Turktekin N, Ozdemir B. Does dehydroepiandrosterone supplementation really affect IVF- ICSI outcomes in women with poor ovarian reserve? Euro J Obstet Gynecol Reprod Biol 2014;173,63-65. https://doi. org/10.1016/j.ejogrb.2013.11.008
Yilmazz N, Uygur D, Inal H, Gorkem U, Cicek N, Mollamahmutoglu L. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: Serum AMH, inhibin B and antral follicle count. Euro J Obstet Gynecol Reprod Biol 2013;169(2),257- 260. https://doi.org/10.1016/j.ejogrb.2013.04.003
Zangmo R, Singh N, Kumar S, Vanamail P, Tiwari A. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles. Reprod Biomed 2014;28(6):743-747. https://doi.org/10.1016/j.rbmo.2014.01.019
Yeung T, Chai J, Li R, Lee V, Ho P, Ng E. A randomised, controlled pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilisation outcomes in poor responders. Fertil Steril 2014;102(1),108-115. https://doi.org/10.1016/j. fertnstert.2014.03.044
Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007;7:S41-S50. https://doi. org/10.1016/j.mito.2007.02.006
Bentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper R. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clin Med Insights: Reprod Health 2014;8:CMRH-S14681. https://doi. org/10.4137/CMRH.S14681
El Refaeey A, Selem A, Badawy A. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. Reprod BioMed 2014;29(1):119-124.
Turi A, Giannubilo S, Brugè F, et al. Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilisation and embryo grading. Arch Gynaecol Obstet 2012;285(4):1173- 1176. https://doi.org/10.1007/s00404-011-2169-2
Gat I, Blanco Mejia S, Balakier H, Librach C, Claessens A, Ryan E. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve. Gynecol Endocrinol 2016;32(7),534-537. https://doi.org/10.3 109/09513590.2015.1137095
Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low- prognosis young women with decreased ovarian reserve: A randomised controlled trial. Reprod Biol Endocrinol 2018;16(1):1-11. https://doi.org/10.1186/s12958-018-0343-0
Caballero T, Fiameni F, Valcarcel A, Buzzi J. Dietary supplementation with coenzyme Q10 in poor responder patients undergoing IVF-ICSI Treatment. Fertil Steril 2016;106(3):e58. https://doi.org/10.1016/j.fertnstert.2016.07.177
Florou P, Anagnostis P, Theocharis P, et al. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized- controlled trials. J Assist Reprod Genet 2020;37:2377-2387. https://doi.org/10.1007/s10815-020-01906-3